Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 1/2007

01-01-2007 | Case Report

Peripheral arterial thrombosis induced by chemotherapy in ovarian carcinoma coexisted with endometrial carcinoma

Authors: Kazuhide Hida, Shun-ichi Ikeda, Shoko Shimizu, Remi Yoshikata, Seiya Orito, Ayano Tatsuduki, Hiroaki Ohta

Published in: Archives of Gynecology and Obstetrics | Issue 1/2007

Login to get access

Abstract

Introduction

Most patients with peripheral arterial occlusion have underlying atherosclerosis. Peripheral arterial thrombosis induced by chemotherapy in gynecological malignancies is rare.

Case report

A 60-year-old woman was diagnosed with ovarian carcinoma coexisting with endometrial carcinoma after surgical histopathological examination. Chemotherapy was started on postoperative day 11. On day 2 of chemotherapy, she developed bilateral lower extremity cyanosis. Thrombocytopenia due to chemotherapy was diagnosed and treated with repeated platelet transfusions. Anticoagulant therapy was also continued. However, the patient worsened steadily and died of liver dysfunction due to multiple liver metastases.

Conclusion

Although arterial thrombosis induced by chemotherapy is rare, it is important for physicians to consider this possibility in the course of treatment with cytotoxic agents because this complication has serious health implications.
Literature
1.
go back to reference Scates S (1992) Diagnosis and treatment of cancer-related thrombosis. Hematol Oncol Clin North Am 6:1329–1339PubMed Scates S (1992) Diagnosis and treatment of cancer-related thrombosis. Hematol Oncol Clin North Am 6:1329–1339PubMed
2.
go back to reference Czaykowski PM, Moore MJ, Tannock IF (1998) High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. J Urol 160:2021–2024PubMedCrossRef Czaykowski PM, Moore MJ, Tannock IF (1998) High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. J Urol 160:2021–2024PubMedCrossRef
3.
go back to reference Wall JG, Weiss RB, Norton L, Perloff M, Rice MA, Korzun AH, Wood WC (1989) Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. Am J Med 87:501–504PubMedCrossRef Wall JG, Weiss RB, Norton L, Perloff M, Rice MA, Korzun AH, Wood WC (1989) Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. Am J Med 87:501–504PubMedCrossRef
4.
go back to reference Donati MB (1995) Cancer and thrombosis: from phlegmasia albadolens to transgenic mice. Thromb Haemost 74:278–281PubMed Donati MB (1995) Cancer and thrombosis: from phlegmasia albadolens to transgenic mice. Thromb Haemost 74:278–281PubMed
5.
go back to reference Falanga A, Donati MB (2001) Pathogenesis of thrombosis in patients with malignancy. Int J Hematol 73:137–144PubMedCrossRef Falanga A, Donati MB (2001) Pathogenesis of thrombosis in patients with malignancy. Int J Hematol 73:137–144PubMedCrossRef
6.
go back to reference Doll DC, Ringenberg QS, Yarbro JW (1986) Vasucular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405–1417PubMed Doll DC, Ringenberg QS, Yarbro JW (1986) Vasucular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405–1417PubMed
7.
go back to reference Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349:1227–1235PubMedCrossRef Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349:1227–1235PubMedCrossRef
8.
go back to reference Andrew EG, Keith M, Peter GR (2002) Arterial thrombosis in a gynecologic oncology patient: evaluation and management. Gynecol Oncol 87:228–230CrossRef Andrew EG, Keith M, Peter GR (2002) Arterial thrombosis in a gynecologic oncology patient: evaluation and management. Gynecol Oncol 87:228–230CrossRef
9.
go back to reference Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, Edwards R, Headley E, Kim SH, O’Donnell JR, O’Dell R, Tornyos K, Kwaan HC (1981) Effect of warfarin on survival in small cell carcinoma of the lung. JAMA 245:831–835PubMedCrossRef Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, Edwards R, Headley E, Kim SH, O’Donnell JR, O’Dell R, Tornyos K, Kwaan HC (1981) Effect of warfarin on survival in small cell carcinoma of the lung. JAMA 245:831–835PubMedCrossRef
10.
go back to reference Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, Edwards RL, Headley E, Kim SH, O’Donnell JF (1984) Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 53:2046–2052PubMedCrossRef Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, Edwards RL, Headley E, Kim SH, O’Donnell JF (1984) Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 53:2046–2052PubMedCrossRef
11.
go back to reference Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL (1989) A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the cancer and leukemia group B. J Clin Oncol 7:993–1002PubMed Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL (1989) A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the cancer and leukemia group B. J Clin Oncol 7:993–1002PubMed
12.
go back to reference Maurer LH, Herndon JE 2nd, Hollis DR, Aisner J, Carey RW, Skarin AT, Perry MC, Eaton WL, Zacharski LL, Hammond S, Green MR (1997) Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. J Clin Oncol 15:3378–3387PubMed Maurer LH, Herndon JE 2nd, Hollis DR, Aisner J, Carey RW, Skarin AT, Perry MC, Eaton WL, Zacharski LL, Hammond S, Green MR (1997) Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. J Clin Oncol 15:3378–3387PubMed
13.
go back to reference Lebeau B, Chastang C, Brechot JM, Capron F, Dautzenberg B, Delaisements C, Mornet M, Brun J, Hurdebourcq JP, Lemarie E (1994) Subcutaneous heparin treatment increases survival in small cell lung cancer. “Petites Cellules” Group. Cancer 74:38–45PubMedCrossRef Lebeau B, Chastang C, Brechot JM, Capron F, Dautzenberg B, Delaisements C, Mornet M, Brun J, Hurdebourcq JP, Lemarie E (1994) Subcutaneous heparin treatment increases survival in small cell lung cancer. “Petites Cellules” Group. Cancer 74:38–45PubMedCrossRef
Metadata
Title
Peripheral arterial thrombosis induced by chemotherapy in ovarian carcinoma coexisted with endometrial carcinoma
Authors
Kazuhide Hida
Shun-ichi Ikeda
Shoko Shimizu
Remi Yoshikata
Seiya Orito
Ayano Tatsuduki
Hiroaki Ohta
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 1/2007
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-006-0193-4

Other articles of this Issue 1/2007

Archives of Gynecology and Obstetrics 1/2007 Go to the issue